| Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription G Zou, X Zhang, L Wang, X Li, T Xie, J Zhao, J Yan, L Wang, H Ye, S Jiao, ... Theranostics 10 (15), 6839, 2020 | 81 | 2020 |
| Advances and prospects in stem cells for cartilage regeneration M Wang, Z Yuan, N Ma, C Hao, W Guo, G Zou, Y Zhang, M Chen, S Gao, ... Stem cells international 2017 (1), 4130607, 2017 | 75 | 2017 |
| Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion KP Ko, Y Huang, S Zhang, G Zou, B Kim, J Zhang, S Jun, C Martin, ... Gastroenterology 165 (3), 613-628. e20, 2023 | 18 | 2023 |
| Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer J Zhao, H Bai, X Li, J Yan, G Zou, L Wang, X Li, Z Liu, R Xiang, XL Yang, ... Signal Transduction and Targeted Therapy 6 (1), 303, 2021 | 14 | 2021 |
| An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway X Zhang, G Zou, X Li, L Wang, T Xie, J Zhao, L Wang, S Jiao, R Xiang, ... Cancer Biology & Medicine 17 (3), 693, 2020 | 13 | 2020 |
| Wnt signaling in liver regeneration, disease, and cancer G Zou, JI Park Clinical and Molecular Hepatology 29 (1), 33, 2023 | 11 | 2023 |
| Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis S Zhang, SH Lee, L Nie, Y Huang, G Zou, YS Jung, S Jun, J Zhang, ... Cancer Communications 43 (1), 159, 2023 | 2 | 2023 |
| CRACD loss promotes small cell lung cancer tumorigenesis via EZH2-mediated immune evasion S Zhang, KB Kim, Y Huang, DW Kim, B Kim, KP Ko, G Zou, J Zhang, S Jun, ... bioRxiv, 2023 | 1 | 2023 |
| CRACD, a gatekeeper restricting proliferation, heterogeneity, and immune evasion of small cell lung cancer S Zhang, KB Kim, Y Huang, DW Kim, B Kim, KP Ko, G Zou, J Zhang, S Jun, ... bioRxiv, 2023.02. 15.528365, 2023 | 1 | 2023 |
| CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma B Kim, S Zhang, Y Huang, KP Ko, YS Jung, J Jang, G Zou, J Zhang, S Jun, ... Cell Reports 43 (6), 2024 | | 2024 |
| Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer KP Ko, S Zhang, Y Huang, B Kim, G Zou, S Jun, J Zhang, Y Zhao, ... Iscience 27 (5), 2024 | | 2024 |
| E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming G Zou, Y Huang, S Zhang, KP Ko, B Kim, J Zhang, V Venkatesan, ... Journal of Experimental Medicine 221 (4), 2024 | | 2024 |
| SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel K Yamashita, M Sewastjanow-Silva, K Yoshimura, JE Rogers, ... Cancers 16 (7), 1300, 2024 | | 2024 |
| Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective G Zou, J Anwar, MP Pizzi, A Abdelhakeem Journal of Thoracic Disease, 2024 | | 2024 |
| CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion G Zou, Y Huang, S Zhang, KP Ko, B Kim, J Zhang, V Venkatesan, ... bioRxiv, 2023 | | 2023 |
| CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma B Kim, S Zhang, Y Huang, KP Ko, G Zou, J Zhang, S Jun, KB Kim, ... bioRxiv, 2023 | | 2023 |
| CRACD/KIAA1211 loss drives cell plasticity and immune evasion of small cell lung cancer S Zhang, KB Kim, Y Huang, DW Kim, B Kim, KP Ko, G Zou, J Zhang, S Jun, ... Cancer Research 83 (7_Supplement), 1714-1714, 2023 | | 2023 |
| PCLAF-DREAM Drives Alveolar Cell Plasticity for Lung Regeneration B Kim, Y Huang, KP Ko, S Zhang, G Zou, J Zhang, MJ Kim, D Little, ... bioRxiv, 2022.10. 11.511761, 2022 | | 2022 |
| Modeling and dissecting of esophageal squamous cell carcinoma initiation KP Ko, G Zou, Y Huang, B Kim, J Zhang, S Jun, JI Park Cancer Research 82 (12_Supplement), 943-943, 2022 | | 2022 |
| CRACD/CRAD, a tumor suppressor for gastric cancer development G Zou, Y Huang, KP Ko, S Zhang, BJ Kim, J Zhang, S Jun, YS Jung, ... Cancer Research 82 (12_Supplement), 836-836, 2022 | | 2022 |
Jae-Il ParkProfessor, Experimental Radiation Oncology, MD Anderson Cancer CenterVerified email at mdanderson.org
